期刊文献+

选择性COX-2抑制剂NS-398对宫颈癌细胞增殖和凋亡的影响 被引量:2

Effects of selective cyclooxygenase-2 inhibitor NS-398 on proliferation and apoptosis of cervical carcinoma cells
下载PDF
导出
摘要 目的研究选择性COX-2抑制剂NS-398对宫颈癌细胞增殖和凋亡的影响。方法不同浓度NS-398处理体外培养的人宫颈癌细胞系Hela细胞后,采用噻唑蓝(MTT)法检测处理48h、72h后hela细胞的增殖活性,流式细胞仪测定细胞周期和细胞凋亡。结果50、100、200umol/LNS-398处理hela细胞48h,72h后,细胞增殖明显受到抑制,呈时间和剂量依赖性特点。200umol/LNS-398处理hela细胞48h后,流式细胞仪细胞周期分析表明,NS-398处理组G1期细胞明显增加,S期细胞明显减少。而细胞凋亡指数无明显变化。结论体外实验表明,NS-398能有效抑制宫颈癌细胞生长,其机制可能与其阻滞细胞周期有关。 [Objective] To evaluate the anti-prollferative and apoptotic effect of NS-398,a selective COX-2 inhibitor, on human cervical carcinoma cell line Hela in vitro. [Method] Hela ceils were treated with different concentrations of NS-398 for 48 and 72 h. the proliferation of Hela cells was studied by MTT assay. The cell cycle distribution and apoptotic index were detected by flow cytometry analysis. [Results] NS-398 results in significant antiproliferafive effects on hela ceils in dose and time-dependent. After treated with 200 umol/L NS-398 for 48 h, NS- 398 increased the proportion of cells in the G1 phrase and decreased the proportion in the S phrase of the cell cycle. however, the apoptotic index showed no difference. [Conclusion] NS-398 could effectively suppress the growth of hela cells in vitro, the mechanism probably relates to its blockage of cell cycle.
出处 《中国医学工程》 2006年第5期462-465,共4页 China Medical Engineering
关键词 宫颈癌 HELA细胞 NS-398 增殖 凋亡 human cervical carcinoma hela cell NS-398 proliferation apoptosis
  • 相关文献

参考文献3

二级参考文献5

共引文献60

同被引文献14

  • 1Ji Yeon Baek,Wonhee Hur,Jin Sang Wang,Si Hyun Bae,Seung Kew Yoon.Selective COX-2 inhibitor,NS-398,suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest[J].World Journal of Gastroenterology,2007,13(8):1175-1181. 被引量:27
  • 2Li Y, Wang Y, Jia C, et al. Detection of human papillomavirus genotypes with liquid bead microarray in cervical lesions of northern Chinese patients[ J]. Cancer Genet Cytogenet, 2008,182 (1) :12 -17.
  • 3Singh N, Jabeen T, Somvanshi RK, et al. Phospholipase A2 as a target protein for nonsteroidal anti-inflammatory drugs (NSAIDS): crystal structure of the complex formed between phospholipase A2 and oxyphenbutazone at 1.6 A resolution [ J ].Biochemistry, 2004,43 ( 46 ) : 14577 - 14583.
  • 4Laye JP, Gill JH. Phospholipase A2 expression in turoours: a target for therapeutic intervention? [ J ]. Drug Discov Today, 2003,8(15) :710 -716.
  • 5Bruno IG, Jin W, Cote GJ. Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements [ J ]. Hum Mol Genet ,2004,13 ( 20 ) :2409 - 2420.
  • 6Rescan C, Le Bras S. EGF-induced proliferation of adult human pancreatic duct cells is mediated by the MEK/ERK cascade[ J]. Lab Invest ,2005,85 ( 1 ) :65 -74.
  • 7Tsou JH, Chang KY, Wang WC, et al. Nucleolin regulates c-Jun/Spl-dependent transcriptional activation of cPLA2 alpha in phorbol ester-treated non-small cell lung cancer A549 cells [ J ]. Nucleic Acids Res, 2008,36 ( 1 ) :217 - 227.
  • 8Xu L,Han C,Lim K,et al. Cross-talk between peroxisome proliferator-activated receptorδ and cytosotic phospholipase A (2) cyclooxygenase-2/prostaglandin E (2) signaling pathways in human hepatocellular carcinoma cells [ J ]. Cancer Res, 2006,66 (24) :11859 - 11868.
  • 9Boonstra J, van Rossum GS. The role of cytosolic phospholipase A2 in celt cycle progression[ J ]. Prog Cell Cycle Res, 2003,5: 181 - 190.
  • 10Sanchez T, Moreno JJ. The effect of high molecular phospholipase A2 inhibitors on 3T6 fibroblast proliferation [ J ]. Biochem Pharmacol,2001,61 ( 7 ) :811 - 816.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部